BioSpace News Archive

Intec Pharma Ltd. announces that the results from a pharmacokinetics study of the Accordion Pill™-Carbidopa/Levodopa 50/500 mg dosed three times per day was accepted for presentation in a poster at the upcoming XXIV World Congress on Parkinson’s Disease and Related Disorders taking place June 16-19, 2019 at the Lyon Convention Centre in Montreal, Canada.

Dr. Greg Simon will receive American Foundation for Suicide Prevention’s Lifesavers Research Award

Dicerna™ Pharmaceuticals, Inc. (Nasdaq:DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the submission of an updated investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for DCR-PHXC, the Company’s lead GalXC™ product candidate for the treatment of all forms of primary hyperoxaluria (PH).

Centene Corporation (NYSE: CNC) announced today it will present at two healthcare conferences in May.

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (‘KALY’) today announced the all new HempTantation, a hemp derived CBD infused sunscreen. KALY has a U.S. Patented cannabis extraction process.

Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and infectious diseases announces the signing of a collaborative research, option and exclusive license agreement with AstraZeneca to co-develop five armed oncolytic vaccinia virus candidates.

GenomOncology announces Northwestern Memorial Healthcare has chosen the GenomOncology Pathology Workbench system as part of its clinical analysis process for their latest Oncomine Comprehensive NGS Assay.

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will host a conference call and webcast on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2019.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2019.

Data presented during “The Role of the Tie2 Pathway in Ocular Disease” symposium at the Association for Research in Vision and Ophthalmology (ARVO) 2019 Annual Meeting